4.5 Article

Synthesis, Binding Affinity Analysis, and 18F Radiosynthesis of Small-Molecular-Weight HIF-1α-Binding Compounds

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma

Elshad Hasanov et al.

Summary: Von Hippel-Lindau (VHL) disease is a genetic syndrome caused by mutations in the VHL gene, resulting in tumors and cysts in multiple organs. Surgery is the standard treatment for localized tumors, but repeated surgeries lead to significant morbidity. MK-6482, a small-molecule HIF 2 alpha inhibitor, has shown promising efficacy and safety in VHL disease-related tumors.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Review Chemistry, Organic

Computational methods in drug discovery

Sumudu P. Leelananda et al.

BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2016)

Review Chemistry, Medicinal

Targeting Protein-Protein Interactions in the HIF System

Sarah E. Wilkins et al.

CHEMMEDCHEM (2016)

Article Multidisciplinary Sciences

Targeting renal cell carcinoma with a HIF-2 antagonist

Wenfang Chen et al.

NATURE (2016)

Article Chemistry, Multidisciplinary

Sonogashira cross-coupling reaction with 4-[18F]fluoroiodobenzene for rapid 18F-labelling of peptides

Jenilee D. Way et al.

CHEMICAL COMMUNICATIONS (2015)

Article Biochemical Research Methods

Radiosynthesis and click' conjugation of ethynyl-4-[18F]fluorobenzene an improved [18F]synthon for indirect radiolabeling

Maxine P. Roberts et al.

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2015)

Review Pharmacology & Pharmacy

HIF-1α pathway: role, regulation and intervention for cancer therapy

Georgina N. Masoud et al.

ACTA PHARMACEUTICA SINICA B (2015)

Article Biochemistry & Molecular Biology

Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors

Satoshi Nagao et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor

Jamie L. Rogers et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Chemistry, Multidisciplinary

A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells

Elena Miranda et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)

Review Chemistry, Medicinal

Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors

Yan Xia et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Medicine, Research & Experimental

Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor

Kiyoshi Okamoto et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)

Article Multidisciplinary Sciences

Protein-binding assays in biological liquids using microscale thermophoresis

Christoph J. Wienken et al.

NATURE COMMUNICATIONS (2010)

Article Multidisciplinary Sciences

Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization

KangAe Lee et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Biochemistry & Molecular Biology

Biology of HIF-1 alpha

A. Weidemann et al.

CELL DEATH AND DIFFERENTIATION (2008)

Article Chemistry, Inorganic & Nuclear

Module-assisted synthesis of the bifunctional labelling agent N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB)

P Mäding et al.

APPLIED RADIATION AND ISOTOPES (2005)